A Novel Machine Learning Algorithm to Automatically Predict Visual Outcomes in Intravitreal Ranibizumab-Treated Patients with Diabetic Macular Edema

被引:19
作者
Chen, Shao-Chun [1 ]
Chiu, Hung-Wen [1 ]
Chen, Chun-Chen [1 ]
Woung, Lin-Chung [1 ]
Lo, Chung-Ming [1 ]
机构
[1] Taipei City Hosp, Dept Ophthalmol, Taipei 10632, Taiwan
关键词
artificial neural network; diabetic macular edema; machine learning; ranibizumab; ENDOTHELIAL GROWTH-FACTOR; DEFERRED LASER; PRACTICAL LESSONS; RETINOPATHY; PROMPT; TRIAMCINOLONE; MANAGEMENT; REGRESSION;
D O I
10.3390/jcm7120475
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Artificial neural networks (ANNs) are one type of artificial intelligence. Here, we use an ANN-based machine learning algorithm to automatically predict visual outcomes after ranibizumab treatment in diabetic macular edema. Methods: Patient data were used to optimize ANNs for regression calculation. The target was established as the final visual acuity at 52, 78, or 104 weeks. The input baseline variables were sex, age, diabetes type or condition, systemic diseases, eye status and treatment time tables. Three groups were randomly devised to build, test and demonstrate the accuracy of the algorithms. Results: At 52, 78 and 104 weeks, 512, 483 and 464 eyes were included, respectively. For the training group, testing group and validation group, the respective correlation coefficients were 0.75, 0.77 and 0.70 (52 weeks); 0.79, 0.80 and 0.55 (78 weeks); and 0.83, 0.47 and 0.81 (104 weeks), while the mean standard errors of final visual acuity were 6.50, 6.11 and 6.40 (52 weeks); 5.91, 5.83 and 7.59; (78 weeks); and 5.39, 8.70 and 6.81 (104 weeks). Conclusions: Machine learning had good correlation coefficients for predicating prognosis with ranibizumab with just baseline characteristics. These models could be the useful clinical tools for prediction of success of the treatments.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [2] Scientific Training in the Era of Big Data: A New Pedagogy for Graduate Education
    Aikat, Jay
    Carsey, Thomas M.
    Fecho, Karamarie
    Jeffay, Kevin
    Krishnamurthy, Ashok
    Mucha, Peter J.
    Rajasekar, Arcot
    Ahalt, Stanley C.
    [J]. BIG DATA, 2017, 5 (01) : 12 - 18
  • [3] Objective evaluation of lens clarity after the intravitreal injection of sustained-release dexamethasone implant
    Anayol, Mustafa Alpaslan
    Sekeroglu, Mehmet Ali
    Tirhis, Hakan
    Gulpamuk, Bayram
    Doguizi, Sibel
    Yilmazbas, Pelin
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2016, 42 (10) : 1477 - 1482
  • [4] Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1 - A potential mechanism for vascular permeability in diabetic retinopathy and tumors
    Antonetti, DA
    Barber, AJ
    Hollinger, LA
    Wolpert, EB
    Gardner, TW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) : 23463 - 23467
  • [5] Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
    Bressler, Susan B.
    Glassman, Adam R.
    Almukhtar, Talat
    Bressler, Neil M.
    Ferris, Frederick L.
    Googe, Joseph M., Jr.
    Gupta, Shailesh K.
    Jampol, Lee M.
    Melia, Michele
    Wells, John A., III
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 164 : 57 - 68
  • [6] Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
    Bressler, Susan B.
    Ayala, Allison R.
    Bressler, Neil M.
    Melia, Michele
    Qin, Haijing
    Ferris, Frederick L., III
    Flaxel, Christina J.
    Friedman, Scott M.
    Glassman, Adam R.
    Jampol, Leem.
    Rauser, Michael E.
    [J]. JAMA OPHTHALMOLOGY, 2016, 134 (03) : 278 - 285
  • [7] RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
    Bressler, Susan B.
    Melia, Michele
    Glassman, Adam R.
    Almukhtar, Talat
    Jampol, Lee M.
    Shami, Michel
    Berger, Brian B.
    Bressler, Neil M.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (12): : 2516 - 2528
  • [8] Exploratory Analysis of the Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical Trial
    Bressler, Susan B.
    Qin, Haijing
    Melia, Michele
    Bressler, Neil M.
    Beck, Roy W.
    Chan, Clement K.
    Grover, Sandeep
    Miller, David G.
    [J]. JAMA OPHTHALMOLOGY, 2013, 131 (08) : 1033 - 1040
  • [9] Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment Three-Year Randomized Trial Results
    Elman, Michael J.
    Qin, Haijing
    Aiello, Lloyd Paul
    Beck, Roy W.
    Bressler, Neil M.
    Ferris, Frederick L., III
    Glassman, Adam R.
    Maturi, Raj K.
    Melia, Michele
    [J]. OPHTHALMOLOGY, 2012, 119 (11) : 2312 - 2318
  • [10] Fursova A Zh, 2017, Vestn Oftalmol, V133, P11, DOI 10.17116/oftalma2017133111-18